Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary Site
Study Title
- Cost-effectiveness Study of miRviewג„¢ Mets in Patients With Cancer of Unknown Primary (CUP)
Teva Identifier
- ONCO1miRviewmets
ClinicalTrials.gov Identifier
- NCT01202786
Study Status
- Completed
Trial Condition(s)
- Neoplasms, Unknown Primary
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 05/01/2010 - 04/01/2012
Study Type
Observational
